本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Lyra Therapeutics

7.90
-0.6500-7.60%
盤後7.900.00000.00%19:42 EDT
成交量:5.97萬
成交額:48.26萬
市值:1,262.70萬
市盈率:-0.13
高:8.52
開:8.48
低:7.85
收:8.55
資料載入中...
2025/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/27

重要事件披露

Form 8-K - Current report
2025/06/23

重要事件披露

Form 8-K - Current report
2025/06/09

重要事件披露

Form 8-K - Current report
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/19

重要事件披露

Form 8-K - Current report
2025/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/04/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/13

重要事件披露

Form 8-K - Current report
2025/03/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/16

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/13

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]